Ethyl 2-(2-chloropyridin-3-yl)-2-oxoacetate, 95.0%, 1g

6-BROMO-3-(1-METHYL-1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE, 97.0%, 250mg

2-Chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]benzoic acid, 98%, 5mg

4-(1h-Imidazol-1-yl)butanoic acid, 98+%, 250mg

4-Chloro-2-fluoro-5-methoxyaniline, 97%, 10g

N1-Methylethane-1,2-diamine dihydrochloride, 95.0%, 250mg

(E)-N1,N1,N4,N4-tetramethylbut-2-ene-1,4-diamine, 98%, 1g

4-Dimethylaminobenzylidenerhodanine>98.0%(T)25g

1,1,2-Trimethyl-1H-benzo[e]indole>98.0%(HPLC)(T)100g

5,6-Dimethyl-1H-benzo[d]imidazole, 95.0%, 25g

Dialysis membrane Spectra/Por® 6 MWCO 15,000, 24 mm, 1 Piece(s)

2-(3-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

4-Bromo-5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98.0%, 10g